This handout is for anti-lgi1 encephalitis. Your care team identified this based on: older male (median age 60) with faciobrachial dystonic seizures (fbds) — short (1-3 sec) brief jerks of arm/face; pathognomonic for lgi1 (irani brain 2011 pmid 21416487).
Other reasons your team may use this plan: subacute memory loss + behavioural change + confusion ± seizures — limbic encephalitis with hippocampal involvement on mri; refractory hyponatremia (siadh) — occurs in ~60% of anti-lgi1; lgi1 hypothalamic expression; new-onset seizures in older adult highly responsive to high-dose ivmp — autoimmune epilepsy pivot.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| methylprednisolone | 1 g IV daily × 5 d | IV | daily × 5 d | First-line acute pulse; FBDS often dramatically responsive to high-dose IVMP within days; Graus 2016 PMID 26906964 |
| IVIG | 0.4 g/kg/day × 5 d (total 2 g/kg) | IV | daily × 5 d | First-line combo or alternative; Titulaer 2013 PMID 23290630 |
| plasmapheresis (PLEX) | 5 cycles q48h over 10 d | IV/large-bore | q2 days × 5 | Severe or steroid+IVIG-refractory; alternative to IVIG |
| prednisone | 60 mg PO daily × 2-4 wk then slow taper over 6-12 mo | PO | daily slow taper | Maintenance after IV pulse; slow taper over 6-12 mo to prevent relapse (~25%) |
Plan: Anti-LGI1 acute IVMP pulse + IVIG/PLEX + slow taper + steroid-sparing + SIADH + AED + thymectomy if found (Graus 2016 PMID 26906964; Irani Brain 2011 PMID 21416487)
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Cognitive rehab (memory + executive deficit common — 60% have residua at 2 y); neuropsych at 3 + 6 + 12 + 24 mo; AED management if seizure history (carbamazepine effective specifically in FBDS but LEV preferred initial); slow steroid taper supervision (over 6-12 mo); SIADH follow-up + endocrinology if persistent; pre-DMT vaccinations; PHQ-9 + GAD-7 (post-encephalitis depression common)
Guideline: Graus 2016 IRCNS Position Paper Autoimmune Encephalitis Criteria + Irani Lancet Neurol 2010 LGI1 original description + Irani Brain 2011 FBDS pathognomonic + Titulaer 2013 treatment outcomes + LGI1 outcomes + LGI1 cognitive